Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive”

15,208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 15,208 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05547464
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 497
Testing effectiveness (Phase 2)UnknownNCT03684863
What this trial is testing

Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Who this might be right for
HER2-positive Breast Cancer
Shandong Cancer Hospital and Institute 200
Not applicableUnknownNCT03549052
What this trial is testing

Right Ventricular Echo Assessment in Mitral Valve Replacement

Who this might be right for
Right Ventricular DysfunctionRheumatic Heart Disease
Assiut University 120
Post-approval studies (Phase 4)Study completedNCT00453947
What this trial is testing

Non-Invasive Ventilation in Pulmonary Edema

Who this might be right for
Pulmonary EdemaMyocardial Infarction
Ospedale S. Giovanni Bosco 60
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07601048
What this trial is testing

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Who this might be right for
KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment
Shandong Suncadia Medicine Co., Ltd. 450
Early research (Phase 1)Study completedNCT01149915
What this trial is testing

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more
Threshold Pharmaceuticals 40
Early research (Phase 1)Study completedNCT06224608
What this trial is testing

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Chengdu CoenBiotech Co., Ltd 60
Not applicableUnknownNCT02945917
What this trial is testing

Positive End-expiratory Pressure and Esophageal Catheter Optimal Calibration Volume in ARDS Patients

Who this might be right for
ARDS
Magni Federico 16
Testing effectiveness (Phase 2)WithdrawnNCT03203616
What this trial is testing

Kadcyla In pAtients With bRAin Metastasis

Who this might be right for
Metastatic HER2-positive Breast Cancer With Brain Metastasis
Jules Bordet Institute
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT01375049
What this trial is testing

Aztreonam Lysine for Pseudomonas Infection Eradication Study

Who this might be right for
Cystic Fibrosis
Gilead Sciences 105
Not applicableLooking for participantsNCT05257538
What this trial is testing

FMT in Initial CDI

Who this might be right for
Clostridioides Difficile Infection
Turku University Hospital 140
Testing effectiveness (Phase 2)Study completedNCT00244855
What this trial is testing

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

Who this might be right for
Contiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Marginal Zone Lymphoma+20 more
Fred Hutchinson Cancer Center 32
Early research (Phase 1)Study completedNCT06438978
What this trial is testing

Tuberculosis Vaccine in Healthy Indian Adults

Who this might be right for
Tuberculosis
Bharat Biotech International Limited 30
Large-scale testing (Phase 3)Ended earlyNCT04453293
What this trial is testing

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

Who this might be right for
Tuberculosis Infection
Henry M. Jackson Foundation for the Advancement of Military Medicine 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT02143414
What this trial is testing

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)UnknownNCT03389815
What this trial is testing

A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid Tumor, Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 48
Testing effectiveness (Phase 2)UnknownNCT05241899
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Who this might be right for
Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 56
Next Page